Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size, Status and Forecast 2024-2031

Report ID: 1012334 | Published Date: Oct 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Surgery
        1.2.3 Targeted Therapy
        1.2.4 Radiation Therapy
        1.2.5 ChemOthersapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Perspective (2016-2027)
    2.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Growth Trends by Regions
        2.2.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Industry Dynamic
        2.3.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Trends
        2.3.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Drivers
        2.3.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Challenges
        2.3.4 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Players by Revenue
        3.1.1 Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue
    3.4 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Concentration Ratio
        3.4.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue in 2020
    3.5 Gastrointestinal Stromal Tumors (GSTs) Treatment Key Players Head office and Area Served
    3.6 Key Players Gastrointestinal Stromal Tumors (GSTs) Treatment Product Solution and Service
    3.7 Date of Enter into Gastrointestinal Stromal Tumors (GSTs) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Stromal Tumors (GSTs) Treatment Breakdown Data by Type
    4.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Stromal Tumors (GSTs) Treatment Breakdown Data by Application
    5.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2016-2027)
    6.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        6.2.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2027)
    6.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        6.3.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2027)
    6.4 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        6.4.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2016-2027)
    7.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        7.2.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2027)
    7.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        7.3.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2027)
    7.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        7.4.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        8.2.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        8.3.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region
        8.4.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2016-2027)
    9.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        9.2.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        9.3.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        9.4.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        10.2.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        10.3.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        10.4.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.1.4 Pfizer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.1.5 Pfizer Recent Development
    11.2 Bayer
        11.2.1 Bayer Company Details
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.2.4 Bayer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.2.5 Bayer Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.3.4 Novartis Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.3.5 Novartis Recent Development
    11.4 Immunicum
        11.4.1 Immunicum Company Details
        11.4.2 Immunicum Business Overview
        11.4.3 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.4.4 Immunicum Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.4.5 Immunicum Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.5.4 Roche Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.5.5 Roche Recent Development
    11.6 AB Science
        11.6.1 AB Science Company Details
        11.6.2 AB Science Business Overview
        11.6.3 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.6.4 AB Science Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.6.5 AB Science Recent Development
    11.7 Arog Pharmaceuticals
        11.7.1 Arog Pharmaceuticals Company Details
        11.7.2 Arog Pharmaceuticals Business Overview
        11.7.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.7.4 Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.7.5 Arog Pharmaceuticals Recent Development
    11.8 Boston Biomedical
        11.8.1 Boston Biomedical Company Details
        11.8.2 Boston Biomedical Business Overview
        11.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.8.4 Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.8.5 Boston Biomedical Recent Development
    11.9 Sun Pharmaceutical
        11.9.1 Sun Pharmaceutical Company Details
        11.9.2 Sun Pharmaceutical Business Overview
        11.9.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.9.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.9.5 Sun Pharmaceutical Recent Development
    11.10 Natco Pharma
        11.10.1 Natco Pharma Company Details
        11.10.2 Natco Pharma Business Overview
        11.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.10.4 Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
        11.10.5 Natco Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Surgery
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Radiation Therapy
    Table 5. Key Players of ChemOthersapy
    Table 6. Key Players of Others
    Table 7. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Regions (2016-2021)
    Table 11. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Regions (2022-2027)
    Table 13. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Trends
    Table 14. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Drivers
    Table 15. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Challenges
    Table 16. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Restraints
    Table 17. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Players (2016-2021)
    Table 19. Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment as of 2020)
    Table 20. Ranking of Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Gastrointestinal Stromal Tumors (GSTs) Treatment Product Solution and Service
    Table 24. Date of Enter into Gastrointestinal Stromal Tumors (GSTs) Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Type (2016-2021)
    Table 28. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Application (2016-2021)
    Table 32. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Pfizer Company Details
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 67. Pfizer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 68. Pfizer Recent Development
    Table 69. Bayer Company Details
    Table 70. Bayer Business Overview
    Table 71. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 72. Bayer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 73. Bayer Recent Development
    Table 74. Novartis Company Details
    Table 75. Novartis Business Overview
    Table 76. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 77. Novartis Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 78. Novartis Recent Development
    Table 79. Immunicum Company Details
    Table 80. Immunicum Business Overview
    Table 81. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 82. Immunicum Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 83. Immunicum Recent Development
    Table 84. Roche Company Details
    Table 85. Roche Business Overview
    Table 86. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 87. Roche Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 88. Roche Recent Development
    Table 89. AB Science Company Details
    Table 90. AB Science Business Overview
    Table 91. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 92. AB Science Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 93. AB Science Recent Development
    Table 94. Arog Pharmaceuticals Company Details
    Table 95. Arog Pharmaceuticals Business Overview
    Table 96. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 97. Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 98. Arog Pharmaceuticals Recent Development
    Table 99. Boston Biomedical Company Details
    Table 100. Boston Biomedical Business Overview
    Table 101. Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 102. Boston Biomedical Recent Development
    Table 103. Sun Pharmaceutical Company Details
    Table 104. Sun Pharmaceutical Business Overview
    Table 105. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 106. Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 107. Sun Pharmaceutical Recent Development
    Table 108. Natco Pharma Company Details
    Table 109. Natco Pharma Business Overview
    Table 110. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 111. Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021) & (US$ Million)
    Table 112. Natco Pharma Recent Development
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Surgery Features
    Figure 3. Targeted Therapy Features
    Figure 4. Radiation Therapy Features
    Figure 5. ChemOthersapy Features
    Figure 6. Others Features
    Figure 7. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application: 2020 VS 2027
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Ambulatory Surgical Centers Case Studies
    Figure 11. Others Case Studies
    Figure 12. Gastrointestinal Stromal Tumors (GSTs) Treatment Report Years Considered
    Figure 13. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Regions: 2020 VS 2027
    Figure 16. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Regions (2022-2027)
    Figure 17. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Players in 2020
    Figure 18. Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue in 2020
    Figure 20. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Type (2016-2021)
    Figure 21. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Type (2022-2027)
    Figure 22. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2016-2027)
    Figure 24. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2016-2027)
    Figure 25. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Country (2016-2027)
    Figure 26. United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2016-2027)
    Figure 30. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2016-2027)
    Figure 31. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Country (2016-2027)
    Figure 32. Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Region (2016-2027)
    Figure 42. China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2016-2027)
    Figure 50. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2016-2027)
    Figure 51. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Country (2016-2027)
    Figure 52. Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Country (2016-2027)
    Figure 58. Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 62. Bayer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 63. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 64. Immunicum Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 65. Roche Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 66. AB Science Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 67. Arog Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 68. Boston Biomedical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 69. Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 70. Natco Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma
Frequently Asked Questions
Gastrointestinal Stromal Tumors (GSTs) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Stromal Tumors (GSTs) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Stromal Tumors (GSTs) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Anal Fistula Drugs

Medications for anal fissures such as topical nitrates, calcium channel blockers, and onabotulinu ... Read More